Instituto de Investigación en Ciencias Médicas S.A.
San José 10108
0 studies enrolling now · 2 studies all time
What they study most
Early Breast Cancer, Respiratory Syncytial Virus
Studies at this site
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
- A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed